{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:06:28Z","timestamp":1792515988861,"version":"4.5.0"},"reference-count":26,"publisher":"Society of Nuclear Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,4,28]]},"published-print":{"date-parts":[[2026,9]]},"DOI":"10.2967\/jnumed.126.272108","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:03:18Z","timestamp":1783004598000},"page":"1392-1400","source":"Crossref","is-referenced-by-count":1,"title":["PSMA PET\/CT\u2013Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study"],"prefix":"10.2967","volume":"67","author":[{"given":"Andrea","family":"Farolfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina Maria Paola","family":"Sgro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Brusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Dall\u2019Olio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Romei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Presutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Droghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Di Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beniamino","family":"Corcioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Gaudiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mosconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Schiavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"2026091707501232000_67.9.1392.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32401-1"},{"key":"2026091707501232000_67.9.1392.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801993"},{"key":"2026091707501232000_67.9.1392.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.03.048"},{"key":"2026091707501232000_67.9.1392.4","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1007\/s00330-019-06114-x","article-title":"Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings","volume":"29","author":"Purysko","year":"2019","journal-title":"Eur Radiol."},{"key":"2026091707501232000_67.9.1392.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.08.002"},{"key":"2026091707501232000_67.9.1392.6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.euo.2022.04.006","article-title":"Diagnostic performance of prostate-specific membrane antigen positron emission tomography-targeted biopsy for detection of clinically significant prostate cancer: a systematic review and meta-analysis","volume":"5","author":"Kawada","year":"2022","journal-title":"Eur Urol Oncol."},{"key":"2026091707501232000_67.9.1392.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.229997"},{"key":"2026091707501232000_67.9.1392.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.250597"},{"key":"2026091707501232000_67.9.1392.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.226498"},{"key":"2026091707501232000_67.9.1392.10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00259-023-06534-4","article-title":"Total-body PET\/CT or LAFOV PET\/CT? Axial field-of-view clinical classification","volume":"51","author":"Mingels","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026091707501232000_67.9.1392.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05282-7"},{"key":"2026091707501232000_67.9.1392.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.238113"},{"key":"2026091707501232000_67.9.1392.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04843-6"},{"key":"2026091707501232000_67.9.1392.14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13550-023-01066-2","article-title":"Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients","volume":"14","author":"Smith","year":"2024","journal-title":"EJNMMI Res."},{"key":"2026091707501232000_67.9.1392.15","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1007\/s00259-021-05420-1","article-title":"pharmacokinetic studies of [68Ga]Ga-PSMA-11 in patients with biochemical recurrence of prostate cancer: detection, differences in temporal distribution and kinetic modelling by tissue type","volume":"48","author":"Strauss","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026091707501232000_67.9.1392.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06475-y"},{"key":"2026091707501232000_67.9.1392.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-011-2377-y"},{"key":"2026091707501232000_67.9.1392.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.033"},{"key":"2026091707501232000_67.9.1392.19","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","article-title":"68Ga-PSMA PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0","volume":"44","author":"Fendler","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026091707501232000_67.9.1392.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263448"},{"key":"2026091707501232000_67.9.1392.21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE V2)","volume":"83","author":"Seifert","year":"2023","journal-title":"Eur Urol."},{"key":"2026091707501232000_67.9.1392.22","doi-asserted-by":"crossref","first-page":"102348","DOI":"10.1016\/j.clgc.2025.102348","article-title":"PSMA-targeted biopsy with fusion guidance for detecting clinically significant prostate cancer in men with negative MRI-feasibility and diagnostic performance of a pilot single-center prospective study","volume":"23","author":"Bianchi","year":"2025","journal-title":"Clin Genitourin Cancer."},{"key":"2026091707501232000_67.9.1392.23","doi-asserted-by":"crossref","first-page":"e230024","DOI":"10.1148\/ryai.230024","article-title":"TotalSegmentator: robust segmentation of 104 anatomic structures in CT images","volume":"5","author":"Wasserthal","year":"2023","journal-title":"Radiol Artif Intell."},{"key":"2026091707501232000_67.9.1392.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2024.10.026"},{"key":"2026091707501232000_67.9.1392.25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.euo.2023.11.008","article-title":"Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography\/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer","volume":"7","author":"Buteau","year":"2024","journal-title":"Eur Urol Oncol."},{"key":"2026091707501232000_67.9.1392.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.03.003"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:50:41Z","timestamp":1789656641000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,2]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.2967\/jnumed.126.272108"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272108","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]}}}